Breast Biopsy Device Market by Product, Test, Guidance, End-Use

Description

List of Tables

The Breast Biopsy Device Market was valued at USD 998.44 million in 2023, expected to reach USD 1,104.62 million in 2024, and is projected to grow at a CAGR of 10.72%, to USD 2,037.69 million by 2030.

The breast biopsy device market encompasses tools and instruments used to extract breast tissue samples for diagnostic examination of breast cancer and other abnormalities. These devices are critical in diagnosing and staging breast cancer, representing a pivotal step in patient care. Driven by an increasing prevalence of breast cancer and advancements in technology, the demand for minimally invasive and accurate diagnostic solutions is increasing. Core needle biopsies, vacuum-assisted biopsies, and fine needle aspiration are among the primary applications, catering to hospitals, diagnostic centers, and ambulatory surgical centers. Growth is fueled by rising awareness and a growing number of breast cancer screening programs, alongside technological advancements such as automated and image-guided biopsy systems. Emerging markets in Asia-Pacific and Latin America offer promising opportunities due to increased healthcare spending and modernization of medical facilities. However, barriers include the high cost of advanced biopsy devices, regulatory hurdles, and a shortage of skilled professionals to operate sophisticated machinery. These factors can impede market growth. Opportunities for innovation lie in developing cost-effective, smaller, and more precise devices, along with digital health integration for data management and telemedicine support. Collaborations with healthcare providers for training and awareness can further enhance adoption. The market is competitive, with key players continuously investing in R&D to maintain their edge. Developing emerging technologies, such as artificial intelligence and machine learning, can lead to smarter biopsy tools with improved diagnostic accuracy and efficiency. To capitalize on these opportunities, businesses should focus on strategic partnerships and geographic expansion to tap into unexplored markets while addressing regulatory and reimbursement challenges. Offering flexible purchasing models, such as leasing, can also mitigate cost barriers, enhancing accessibility in resource-limited settings. The market's nature is dynamic, underscored by rapid technological advancements and shifting healthcare landscapes, necessitating continuous adaptation to remain competitive.

KEY MARKET STATISTICS
Base Year [2023]	USD 998.44 million
Estimated Year [2024]	USD 1,104.62 million
Forecast Year [2030]	USD 2,037.69 million
CAGR (%)	10.72%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Breast Biopsy Device Market

The Breast Biopsy Device Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Growing cases of breast cancer across the world
- Government initiative for awareness and treatment of breast cancer
- Shifting preferences for early detection and screening for breast cancer
Market Restraints
- Possibilities of infection associated with biopsy needles
Market Opportunities
- Advent of liquid biopsy devices for breast cancer treatment
- On-going clinical trial and increase in new product development
Market Challenges
- Dearth of financial and technical resources

Porter's Five Forces: A Strategic Tool for Navigating the Breast Biopsy Device Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Breast Biopsy Device Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Breast Biopsy Device Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Breast Biopsy Device Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Breast Biopsy Device Market

A detailed market share analysis in the Breast Biopsy Device Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Breast Biopsy Device Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Breast Biopsy Device Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Breast Biopsy Device Market

A strategic analysis of the Breast Biopsy Device Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Breast Biopsy Device Market, highlighting leading vendors and their innovative profiles. These include Advin Health Care, Argon Medical Devices, Inc., Becton, Dickinson and Company, Cook Group Incorporated, Danaher Corporation, FUJIFILM Corporation, GE HealthCare Technologies Inc., Halma plc, Hologic, Inc, INRAD Inc., Medline Industries, LP, Medtronic PLC, Merit Medical Systems, Inc., Ningbo Xinwell Medical Technology Co., LTD., PAJUNK GmbH, Planmeca Oy, Point Blank Medical, Siemens Healthcare GmbH, SNVL Varay Laborix, STERYLAB S.r.l., Suretech Medical Inc., Thermo Fisher Scientific Inc., Trivitron Healthcare, Vector Medical, Inc., and Zamar Care.

Market Segmentation & Coverage

This research report categorizes the Breast Biopsy Device Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Product, market is studied across Biopsy Needles, Biopsy Tables, Guidance Systems, and Localization Wires.
Based on Test, market is studied across Needle Breast Biopsy and Surgical Biopsy. The Needle Breast Biopsy is further studied across Core-Needle Aspiration, Fine-Needle Aspiration, and Vacuum-Assisted Core Biopsy. The Surgical Biopsy is further studied across Excisional Breast Biopsy and Incisional Breast Biopsy.
Based on Guidance, market is studied across Magnetic Resonance-Guided, Mammography-Guided Stereotactic, and Ultrasound-Guided.
Based on End-Use, market is studied across Diagnostic Centers and Hospitals & Clinics.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-807A20B5CD96

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing cases of breast cancer across the world
  - 5.1.1.2. Government initiative for awareness and treatment of breast cancer
  - 5.1.1.3. Shifting preferences for early detection and screening for breast cancer
- 5.1.2. Restraints
  - 5.1.2.1. Possibilities of infection associated with biopsy needles
- 5.1.3. Opportunities
  - 5.1.3.1. Advent of liquid biopsy devices for breast cancer treatment
  - 5.1.3.2. On-going clinical trial and increase in new product development
- 5.1.4. Challenges
  - 5.1.4.1. Dearth of financial and technical resources
5.2. Market Segmentation Analysis
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Breast Biopsy Device Market, by Product

6.1. Introduction
6.2. Biopsy Needles
6.3. Biopsy Tables
6.4. Guidance Systems
6.5. Localization Wires

7. Breast Biopsy Device Market, by Test

7.1. Introduction
7.2. Needle Breast Biopsy
- 7.2.1. Core-Needle Aspiration
- 7.2.2. Fine-Needle Aspiration
- 7.2.3. Vacuum-Assisted Core Biopsy
7.3. Surgical Biopsy
- 7.3.1. Excisional Breast Biopsy
- 7.3.2. Incisional Breast Biopsy

8. Breast Biopsy Device Market, by Guidance

8.1. Introduction
8.2. Magnetic Resonance-Guided
8.3. Mammography-Guided Stereotactic
8.4. Ultrasound-Guided

9. Breast Biopsy Device Market, by End-Use

9.1. Introduction
9.2. Diagnostic Centers
9.3. Hospitals & Clinics

10. Americas Breast Biopsy Device Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Breast Biopsy Device Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Breast Biopsy Device Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation

Companies Mentioned

1. Advin Health Care
2. Argon Medical Devices, Inc.
3. Becton, Dickinson and Company
4. Cook Group Incorporated
5. Danaher Corporation
6. FUJIFILM Corporation
7. GE HealthCare Technologies Inc.
8. Halma plc
9. Hologic, Inc
10. INRAD Inc.
11. Medline Industries, LP
12. Medtronic PLC
13. Merit Medical Systems, Inc.
14. Ningbo Xinwell Medical Technology Co., LTD.
15. PAJUNK GmbH
16. Planmeca Oy
17. Point Blank Medical
18. Siemens Healthcare GmbH
19. SNVL Varay Laborix
20. STERYLAB S.r.l.
21. Suretech Medical Inc.
22. Thermo Fisher Scientific Inc.
23. Trivitron Healthcare
24. Vector Medical, Inc.
25. Zamar Care